Deep Tech Startups

ImmPro provides top-down proteomics analytical services for biopharmaceutical development, using single-particle protein analysis to characterize proteins and proteoforms. Its offerings support gene therapy vector characterization, biomarker discovery, and disease-specific assays for areas such as neurodegeneration, oncology, and cardiometabolic disease.

1 investor

BIIE is a research institute in Basel focused on immune engineering, supporting scientists working on synthetic immunology, computational immunology, and systems immunology. It aims to advance global child health through immune system research.

1 investor

ImmuneSpecs uses immunopeptidomics (MAPPs) technology to identify peptides presented by MHC molecules, enabling precise mapping of T cell epitopes in biotherapeutics and validation of immunotherapy targets. The company serves biopharmaceutical organizations seeking advanced antigen presentation analysis.

1 investor

ImmunoBiochem develops degrader-antibody conjugate (DAC) therapeutics that combine antibody targeting with targeted protein degradation for precision immunology and inflammation. Its pipeline targets autoimmune and inflammatory disorders, using computational tools and disease models to design non-cytotoxic payloads.

1 investor

ImmunoBlue develops nanoimmunotherapies for cancer treatment by combining nanotechnology and immunotherapy. It operates in the biotech and therapeutics space.

1 investor

ImmunoScape is a Singapore-based biotechnology company developing high-throughput immune profiling and therapeutic T cell receptor discovery platforms for immunotherapy and cancer treatment. The company was spun off from Singapore's A*STAR research institute and serves the immunotherapy and oncology sectors.

1 investor

Impact Cooling develops a patented jet impingement air heatsink that serves as a drop-in replacement for traditional finned heatsinks on CPUs, GPUs, and FPGAs. The technology targets data center operators seeking to cool higher-powered server chips while cutting airflow, energy, and water use without liquid cooling.

1 investor

Impact Science Ventures (ISV) is an early-stage venture firm that identifies, invests in, and builds companies commercializing scientific breakthroughs in energy, materials, mining, chemicals, agriculture, and the built environment. It backs founders working on industrial innovation aimed at cost-efficient production, supply chain resilience, and climate goals.

1 investor

Impedans develops plasma diagnostic sensors — including Langmuir probes, retarding field energy analyzers, and RF VI probes — that measure parameters such as ion density, electron temperature, ion energy, and RF power/impedance. Its products are used by semiconductor device manufacturers, plasma equipment makers, research institutes, and university physics labs across the US, Europe, and Asia.

1 investor

Impli develops implantable biotech devices that enable continuous monitoring of biological data, starting with hormone monitoring applications. The platform is designed to support personalized, preventive healthcare by tracking real-time shifts in stress, fertility, metabolism, and aging.

1 investor

Implicit BioScience develops therapeutic approaches targeting cardioimmunology, specifically using CD14 blockade to modulate immune responses in acute heart attack (STEMI) treatment. The company's work is validated through peer-reviewed research in leading cardiology journals.

1 investor

Impossible Sensing develops remote sensing technologies for space exploration applications and commercializes these capabilities for Earth-based climate mitigation, sustainable agriculture, and deep ocean exploration.

1 investor

Imprint Analytics provides analytical verification and authentication services to detect fraud and verify product origin and authenticity, primarily for food and consumer goods companies. The firm uses techniques like isotope analysis to ensure supply chain integrity and protect consumer trust.

1 investor

Impulse Biomed is a South African medical device company that develops affordable healthcare products, including the ZiBiPen reloadable adrenaline auto-injector and the Easy Squeezy inhaler attachment for asthma and allergy care. It focuses on making life-saving medical technologies accessible in under-resourced settings.

1 investor

IMS Group is a global private investment partnership that deploys capital across multiple divisions focused on specialist credit, venture building, and technology infrastructure. The group operates through four divisions—Capital Management, Digital Ventures, Labs, and Sports Capital—leveraging proprietary AI-driven platforms and a network of family offices and operators to invest in underserved opportunities across fintech, enterprise software, blockchain, and dual-use technologies.

1 investor

IMS Nanofabrication is a high-tech company specializing in electron-beam lithography, developing and manufacturing multi-electron-beam writers for semiconductor industry manufacturers. It operates in nanotechnology serving global semiconductor players.

1 investor

IMSystems develops the Archimedes Drive, a traction-based precision speed reducer that transmits torque through hollow steel rollers to achieve zero backlash and low lost motion for robotics applications. The drive targets humanoids and advanced robots requiring precise, quiet, and durable motion in joints and mobile manipulators.

1 investor

Imvizar builds augmented reality and immersive storytelling experiences that enhance physical locations for attractions, businesses, and brands. It combines interaction design and narrative content to improve the visitor experience at places and spaces.

1 investor

In A Blink develops edge routers and optical wireless communication solutions for transit vehicles, offering high-speed data transmission, cybersecurity, and edge computing capabilities for vehicle-to-infrastructure connectivity.

1 investor

inait develops "Digital Brain" AI based on causal, brain-inspired learning that can learn cause and effect and accumulate cognitive skills in dynamic environments. It targets multiple industry verticals with its inait Adaptive Machines (iAMs), starting with finance and robotics.

1 investor

Inanimate is building technology for what it calls Universal Ambient Intelligence, aiming to augment users' physical environments and increase their agency. The company is an early-stage deep tech venture based in London.

1 investor

INBRAIN Neuroelectronics develops graphene-based brain-computer interfaces that decode and modulate neural signals, combined with AI, to deliver personalized neurotherapies starting with brain disorders such as Parkinson's disease and epilepsy. The company builds implantable bioelectronic medicine for neurological patients and clinical/neurosurgical applications, and is based in Barcelona, Spain.

1 investor

Incipientus develops touch-free, in-line sensor solutions for process industries to monitor and analyze non-Newtonian liquids without invasion. The company enables manufacturers to optimize production efficiency, reduce waste, and minimize water and chemical usage through continuous dynamic flow analysis.

1 investor

INCIRT develops broadband data conversion technology used in wireless connectivity and sensing systems. Its components serve applications in satellite, radar, space, Wi-Fi, telecommunications, and test-and-measurement equipment.

1 investor